AOBI Stock - American Oriental Bioengineering, Inc.
Unlock GoAI Insights for AOBI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|
| Revenue | $145.10M | $212.69M | $305.94M | $296.15M | $264.64M |
| Gross Profit | $44.36M | $99.75M | $157.76M | $166.78M | $173.61M |
| Gross Margin | 30.6% | 46.9% | 51.6% | 56.3% | 65.6% |
| Operating Income | $-54,972,000 | $-3,545,000 | $30.37M | $58.76M | $63.49M |
| Net Income | $-59,713,000 | $-68,491,000 | $14.09M | $41.42M | $47.06M |
| Net Margin | -41.2% | -32.2% | 4.6% | 14.0% | 17.8% |
| EPS | $-781.24 | $-901.80 | $190.38 | $1112.22 | $621.24 |
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.
Visit WebsiteEarnings History & Surprises
AOBIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2013 | Sep 30, 2013 | — | $-290.36 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-176.28 | — | — |
Q1 2013 | Mar 31, 2013 | — | $-288.69 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-485.66 | — | — |
Q3 2012 | Sep 30, 2012 | — | $250.16 | — | — |
Q2 2012 | Jun 30, 2012 | — | $-328.65 | — | — |
Q1 2012 | Mar 31, 2012 | — | $-217.74 | — | — |
Q4 2011 | Dec 31, 2011 | — | $-1051.57 | — | — |
Q4 2011 | Nov 14, 2011 | $50.10 | $80.16 | +60.0% | ✓ BEAT |
Q3 2011 | Aug 9, 2011 | $70.14 | $50.10 | -28.6% | ✗ MISS |
Q2 2011 | May 9, 2011 | $35.07 | $10.02 | -71.4% | ✗ MISS |
Q1 2011 | Mar 14, 2011 | $83.50 | $40.08 | -52.0% | ✗ MISS |
Q4 2010 | Nov 9, 2010 | $80.16 | $70.14 | -12.5% | ✗ MISS |
Q3 2010 | Aug 9, 2010 | $102.71 | $70.14 | -31.7% | ✗ MISS |
Q2 2010 | May 10, 2010 | $63.46 | $40.08 | -36.8% | ✗ MISS |
Q1 2010 | Mar 15, 2010 | $160.32 | $140.28 | -12.5% | ✗ MISS |
Q4 2009 | Nov 16, 2009 | $170.34 | $130.26 | -23.5% | ✗ MISS |
Q3 2009 | Aug 7, 2009 | $176.35 | $170.34 | -3.4% | ✗ MISS |
Q2 2009 | May 11, 2009 | $118.57 | $110.22 | -7.0% | ✗ MISS |
Q1 2009 | Mar 9, 2009 | $250.50 | $250.50 | 0.0% | = MET |
Latest News
Frequently Asked Questions about AOBI
What is AOBI's current stock price?
What is the analyst price target for AOBI?
What sector is American Oriental Bioengineering, Inc. in?
What is AOBI's market cap?
Does AOBI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AOBI for comparison